Utah Cash from 2010 to 2026

UTMD Stock  USD 64.10  0.37  0.58%   
Utah Medical's Cash is increasing over the years with slightly volatile fluctuation. Overall, Cash is expected to go to about 90 M this year. Cash is the total amount of money in the form of currency that Utah Medical Products has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
1987-12-31
Previous Quarter
84.3 M
Current Value
85.8 M
Quarterly Volatility
26 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Utah Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Utah Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.5 M, Interest Expense of 675.3 K or Total Revenue of 37 M, as well as many indicators such as Price To Sales Ratio of 3.48, Dividend Yield of 0.0242 or PTB Ratio of 1.48. Utah financial statements analysis is a perfect complement when working with Utah Medical Valuation or Volatility modules.
  
Build AI portfolio with Utah Stock
Check out the analysis of Utah Medical Correlation against competitors.
Analyzing Utah Medical's Cash over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Cash has evolved provides context for assessing Utah Medical's current valuation and future prospects.

Latest Utah Medical's Cash Growth Pattern

Below is the plot of the Cash of Utah Medical Products over the last few years. Cash refers to the most liquid asset of Utah Medical Products, which is listed under current asset account on Utah Medical Products balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Utah Medical customers. The amounts must be unrestricted with restricted cash listed in a different Utah Medical account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Utah Medical's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Utah Medical's overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Slightly volatile
   Cash   
       Timeline  

Utah Cash Regression Statistics

Arithmetic Mean45,513,047
Geometric Mean30,874,448
Coefficient Of Variation68.94
Mean Deviation26,619,697
Median42,787,000
Standard Deviation31,374,827
Sample Variance984.4T
Range91.2M
R-Value0.98
Mean Square Error39.8T
R-Squared0.96
Slope6,094,332
Total Sum of Squares15750.1T

Utah Cash History

202690 M
202585.8 M
202483 M
202392.9 M
202275.1 M
202161 M
202051.6 M

Other Fundumenentals of Utah Medical Products

Utah Medical Cash component correlations

About Utah Medical Financial Statements

Utah Medical stakeholders use historical fundamental indicators, such as Utah Medical's Cash, to determine how well the company is positioned to perform in the future. Although Utah Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Utah Medical's assets and liabilities are reflected in the revenues and expenses on Utah Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Utah Medical Products. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash85.8 M90 M
Cash And Short Term Investments85.8 M90 M
Change In Cash-11.4 M-10.8 M
Free Cash Flow16.8 M10.8 M
Begin Period Cash Flow106.8 M112.1 M
Total Cashflows From Investing Activities-187.2 K-196.6 K
Other Cashflows From Financing Activities448.5 K470.9 K
Other Non Cash Items-3.6 K-3.4 K
Total Cash From Operating Activities17.1 M12.8 M
Total Cash From Financing Activities-21.5 M-20.4 M
End Period Cash Flow95.4 M100.2 M
Other Cashflows From Investing Activities24.3 K25.5 K
Cash And Cash Equivalents Changes17.1 M17.9 M
Cash Flows Other Operating-12.7 K-12 K
Free Cash Flow Yield 0.08  0.08 
Operating Cash Flow Per Share 3.81  2.14 
Free Cash Flow Per Share 3.75  3.94 
Cash Per Share 25.91  27.20 
Capex To Operating Cash Flow 0.02  0.02 
EV To Operating Cash Flow 10.29  15.85 
EV To Free Cash Flow 10.45  9.93 
Price To Operating Cash Flows Ratio 16.70  16.67 
Price To Free Cash Flows Ratio 16.97  30.29 
Cash Ratio 33.01  34.66 
Cash Conversion Cycle 170.88  107.41 
Operating Cash Flow Sales Ratio 0.33  0.26 
Free Cash Flow Operating Cash Flow Ratio 0.89  0.66 
Cash Flow Coverage Ratios 39.49  41.47 
Price Cash Flow Ratio 16.70  16.67 
Cash Flow To Debt Ratio 39.49  41.47 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:
Check out the analysis of Utah Medical Correlation against competitors.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Will Health Care Equipment & Supplies sector continue expanding? Could Utah diversify its offerings? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Utah Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.06)
Dividend Share
1.225
Earnings Share
3.51
Revenue Per Share
11.889
Quarterly Revenue Growth
(0.01)
Utah Medical Products's market price often diverges from its book value, the accounting figure shown on Utah's balance sheet. Smart investors calculate Utah Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Utah Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.